Covid-19: India allows paracetamol formulation export, retains curbs on API

Pharma industry welcomes decision, but wants govt to consider allowing export of APIs made before March 3

India on Friday removed restrictions on export of the common pain and fever drug paracetamol, though restrictions on export of raw material for making the drug will remain in place.

The Directorate General of Foreign Trade (DGFT) said in a notification that export of formulations made from paracetamol, including fixed dose combinations (FDCs), was now permitted. However, export of its active pharmaceutical ingredient (API) will remain restricted. For items in the restricted list, exporters have to obtain a ‘no objection certificate’ from the ministry of commerce.